文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

常规筛查中癌胚抗原(CEA)升高揭示IV期肺腺癌

Carcinoembryonic Antigen (CEA) Elevation in Routine Screening Unveils Stage IV Lung Adenocarcinoma.

作者信息

Mohamed Kamel Farha Munira, Muhammad Noor Azimah, Adenan Amir Zharif

机构信息

Family Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, MYS.

Public Health Medicine, Faculty of Medicine, Universiti Teknologi Majlis Amanah Rakyat (MARA) (UiTM), Sungai Buloh, MYS.

出版信息

Cureus. 2025 May 8;17(5):e83751. doi: 10.7759/cureus.83751. eCollection 2025 May.


DOI:10.7759/cureus.83751
PMID:40486318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12145215/
Abstract

Carcinoembryonic antigen (CEA) is a tumor marker most often associated with colorectal cancer, but elevated levels may also indicate other malignancies, including lung cancer. Although not recommended as a standalone screening or diagnostic tool, persistent elevation in CEA levels may warrant further investigation. This case report describes a 71-year-old woman who was found to have progressively rising CEA levels during routine private health screening despite being asymptomatic. Initial workup, including colonoscopy, revealed no evidence of colorectal malignancy. However, further evaluation prompted by new respiratory symptoms and imaging findings led to the diagnosis of Stage IVa lung adenocarcinoma. This case underscores the importance of a comprehensive diagnostic approach in patients with unexplained tumor marker elevation. It highlights the potential role of primary care in identifying atypical presentations of serious conditions.

摘要

癌胚抗原(CEA)是一种最常与结直肠癌相关的肿瘤标志物,但水平升高也可能提示其他恶性肿瘤,包括肺癌。虽然不建议将其作为独立的筛查或诊断工具,但CEA水平持续升高可能需要进一步检查。本病例报告描述了一名71岁女性,在常规私人健康筛查中发现其CEA水平逐渐升高,尽管她没有症状。初步检查,包括结肠镜检查,未发现结直肠恶性肿瘤的证据。然而,新出现的呼吸道症状和影像学检查结果促使进一步评估,最终诊断为IVa期肺腺癌。本病例强调了对肿瘤标志物不明原因升高的患者采用综合诊断方法的重要性。它突出了初级保健在识别严重疾病非典型表现方面的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7601/12145215/76ec0f845439/cureus-0017-00000083751-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7601/12145215/e8c116328ab1/cureus-0017-00000083751-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7601/12145215/76ec0f845439/cureus-0017-00000083751-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7601/12145215/e8c116328ab1/cureus-0017-00000083751-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7601/12145215/76ec0f845439/cureus-0017-00000083751-i02.jpg

相似文献

[1]
Carcinoembryonic Antigen (CEA) Elevation in Routine Screening Unveils Stage IV Lung Adenocarcinoma.

Cureus. 2025-5-8

[2]
Carcinoembryonic antigen-positive pleural effusion in early stage non-small cell lung cancer without pleural infiltration.

J Thorac Dis. 2018-5

[3]
Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusion.

Korean J Intern Med. 2024-3

[4]
Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.

Int J Clin Oncol. 2017-4

[5]
Should a colonoscopy be recommended for healthy individuals with increased carcinoembryonic antigen levels? A case-control study.

Dig Dis Sci. 2011-2-17

[6]
Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion.

Am J Med Sci. 2024-8

[7]
Elevated Level of Serum Carcinoembryonic Antigen (CEA) and Search for a Malignancy: A Case Report.

Cureus. 2016-6-20

[8]
Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.

BMJ Case Rep. 2018-6-11

[9]
Prognostic Role of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 in Stage IV Colorectal Cancer.

Anticancer Res. 2022-8

[10]
[Evaluation of the diagnosis value of carcinoembryonic antigen in malignant pleural effusion].

Zhonghua Yi Xue Za Zhi. 2018-2-6

本文引用的文献

[1]
Meta-analysis of Targeted Therapies in EGFR-mutated Non-Small Cell Lung Cancer: Efficacy and Safety of Osimertinib, Erlotinib, and Gefitinib as First-line Treatment.

Am J Clin Oncol. 2025-1-1

[2]
Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers.

Int J Biol Markers. 2023-6

[3]
Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer.

JAMA Netw Open. 2022-3-1

[4]
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.

Br J Cancer. 2021-9

[5]
Comparison of serum tumor markers combined with dual-source CT in the diagnosis of lung cancer.

Minerva Med. 2023-12

[6]
A Review of the Role of Carcinoembryonic Antigen in Clinical Practice.

Ann Coloproctol. 2019-12

[7]
Combined detection of CEA and CA125 for the diagnosis for lung cancer: A meta-analysis.

Cell Mol Biol (Noisy-le-grand). 2018-12-31

[8]
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?

Dis Markers. 2018-10-1

[9]
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.

Lung Cancer. 2011-12-6

[10]
The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.

J Int Med Res. 2009

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索